臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jin yuan shih"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 106-130 / 468 (共19頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-08-13T06:34:00Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; JIN-YUAN SHIH; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:59Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Yang C.-H.; Yang P.-C.; Huang T.-C.; Lin C.-C.; Yu C.-J.; Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:59Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	JIN-YUAN SHIH; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.; Chen K.-Y.; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.
臺大學術典藏	2020-08-13T06:33:59Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:58Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	JIN-YUAN SHIH; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; Yang P.-C.; Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Yang P.-C.
臺大學術典藏	2020-08-13T06:33:58Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Mok T.; Yang C.-H.; Leung L.; Lam K.C.; Lin C.-C.; Hsu H.-H.; Sun C.-T.; JIN-YUAN SHIH; Lin Z.-Z.; Yu C.-J.; Chen G.G.; Hsin M.K.Y.; Lin C.-C.;Hsu H.-H.;Sun C.-T.;Jin-Yuan Shih;Lin Z.-Z.;Yu C.-J.;Chen G.G.;Hsin M.K.Y.;Lam K.C.;Leung L.;Yang C.-H.;Mok T.
臺大學術典藏	2020-08-13T06:33:57Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	Lee J.-H.;Yu C.-J.;Chen K.-Y.;Jin-Yuan Shih;Lin Y.-L.;Yang C.-H.; Lee J.-H.; Yu C.-J.; Chen K.-Y.; JIN-YUAN SHIH; Lin Y.-L.; Yang C.-H.
臺大學術典藏	2020-08-13T06:33:57Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; JIN-YUAN SHIH; Yang P.-C.; Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Jin-Yuan Shih;Yang P.-C.
臺大學術典藏	2020-08-13T06:33:57Z	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma	Yen R.-F.; Huang C.-T.; Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Jin-Yuan Shih;Yang C.-H.;Yang P.-C.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; JIN-YUAN SHIH; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:56Z	Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations	Chung K.-P.; JIN-YUAN SHIH; Yu C.-J.; Chung K.-P.;Jin-Yuan Shih;Yu C.-J.
臺大學術典藏	2020-08-13T06:33:56Z	Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation	Kuo Y.-W.;Wu S.-G.;Ho C.-C.;Jin-Yuan Shih; Kuo Y.-W.; Wu S.-G.; Ho C.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:56Z	Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women	Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; Lin C.-W.; JIN-YUAN SHIH; Yang P.-C.; Hsiao C.K.; Lai L.-C.; Chuang E.Y.; Lu T.-P.; Lu T.-P.;Tsai M.-H.;Lee J.-M.;Hsu C.-P.;Chen P.-C.;Lin C.-W.;Jin-Yuan Shih;Yang P.-C.;Hsiao C.K.;Lai L.-C.;Chuang E.Y.
臺大學術典藏	2020-08-13T06:33:56Z	Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma	Ueng T.-H.; Chang Y.-L.; Tsai Y.-Y.; Su J.-L.; Chan P.-K.; JIN-YUAN SHIH; Lee Y.-C.; Ma Y.-C.; Kuo M.-L.; Ueng T.-H.;Chang Y.-L.;Tsai Y.-Y.;Su J.-L.;Chan P.-K.;Jin-Yuan Shih;Lee Y.-C.;Ma Y.-C.;Kuo M.-L.
臺大學術典藏	2020-08-13T06:33:55Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	Yang P.-C.; Kuo Y.-W.; Jerng J.-S.; JIN-YUAN SHIH; Chen K.-Y.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:55Z	Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach	Lu S.; Thongprasert S.; Salto-Tellez M.; Tsao M.-S.; JIN-YUAN SHIH; Chang G.-C.; Au J.S.-K.; Chou T.-Y.; Lee J.-S.; Shi Y.-K.; Radzi A.; Kang J.-H.; Kim S.-W.; Tan S.-Y.; Yang J.C.-H.
臺大學術典藏	2020-08-13T06:33:54Z	Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers	Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C.
臺大學術典藏	2020-08-13T06:33:54Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏	2020-08-13T06:33:54Z	Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas	Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C.
臺大學術典藏	2020-08-13T06:33:53Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:53Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:53Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:52Z	Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction	Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:52Z	The role of epidermal growth factor receptor mutations and epidermal growth factor receptor-tyrosine kinase inhibitors in the treatment of lung cancer	Chang S.-C.;Chang C.-Y.;Jin-Yuan Shih; Chang S.-C.; Chang C.-Y.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:52Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:51Z	EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy	Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C.

顯示項目 106-130 / 468 (共19頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856600
	造訪人次 : 53476508 線上人數 : 955 教育部委託研究計畫計畫執行:國立臺灣大學圖書館